Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.

Alberto OcañaMarta Gil-MartinSilvia AntolínMaría AtienzaÁlvaro MontañoNuria RibellesAnder UrruticoecheaAlejandro FalcónSonia PernasJavier OrlandoJuan Carlos MonteroMaria José EscuderoSara BenitoRosalía CaballeroEva CarrascoFederico RojoAtanasio PandiellaManuel Ruiz-Borrego

Published in: Breast cancer research and treatment (2019)

NCT01306942, EudraCT 2010-023304-27.

Keyphrases

metastatic breast cancer
phase ii
clinical trial
open label
phase iii
randomized controlled trial